Welcome to Roivant
Eyes

Reinventing the discovery, development, and commercialization of new medicines

About Us

We develop transformative medicines and technologies by building agile, focused companies called Vants.

Our companies

Our model aligns incentives to drive fast, high-quality execution and rigorous capital allocation.

We employ technology across discovery, development, and commercialization.

Woman Rubbing Her Shoulder

Dermavant

Leading innovation in medical dermatology


Immunovant

Immunovant

Advancing potentially transformative therapies for autoimmune diseases


priovant

Priovant

Developing targeted therapies for patients with severe autoimmune disease


Investor Update
video section decoration

CEO Matt Gline presents on the upcoming year for Roivant at the J.P. Morgan Healthcare Conference in San Francisco, CA

For Investors
For Investors

Learn more about our work

Sign up for our latest announcements and upcoming presentations

Pipeline
Pipeline

Advancing medicines that matter

View our broad and differentiated pipeline of investigational drugs.